Bengaluru startup first Indian firm to get US-FDA Class II nod for medical air cleaners
Bengaluru-based Biomoneta has achieved a significant first, becoming the inaugural Indian healthtech firm to secure US-FDA 510(k) Class II clearance for its innovative medical air-cleaning device. This breakthrough, powered by their unique ZeBox technology, promises to revolutionize hospital infection control by effectively eliminating airborne pathogens, including SARS-CoV-2, paving the way for its deployment in US healthcare facilities.
Bengaluru-based Biomoneta has achieved a significant first, becoming the inaugural Indian healthtech firm to secure US-FDA 510(k) Class II clearance for its innovative medical air-cleaning device. This breakthrough, powered by their unique ZeBox technology, promises to revolutionize hospital infection control by effectively eliminating airborne pathogens, including SARS-CoV-2, paving the way for its deployment in US healthcare facilities.
